These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20948249)

  • 1. [Pain control for bone metastasis using radioactive strontium].
    Yamaguchi K
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1868-71. PubMed ID: 20948249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG; Preston DF; Schiefelbein M; Baxter KG
    JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium-89 for treatment of painful bone metastasis from prostate cancer.
    Altman GB; Lee CA
    Oncol Nurs Forum; 1996 Apr; 23(3):523-7. PubMed ID: 8801513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Internal strontium-89 radiotherapy for malignant bony metastasis].
    Lou C; Zhang D; Yu L
    Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):507-9. PubMed ID: 11859724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
    Brundage MD; Crook JM; Lukka H
    Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [89Sr Therapy for pain relief in patients with bone metastases].
    Koizumi K; Arbab AS; Toyama K; Shirasu M; Osawa S; Araki T; Yamaguchi M; Onishi H; Araki T; Arai T; Komatsu H; Ueno A; Nokata H
    Kaku Igaku; 1996 Nov; 33(11):1243-8. PubMed ID: 8986064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89.
    Sciuto R; Maini CL; Tofani A; Fiumara C; Scelsa MG; Broccatelli M
    Nucl Med Commun; 1996 Sep; 17(9):799-804. PubMed ID: 8895908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of therapy using 89Sr-strontium chloride in 200 patients with bone metastases of a prostatic cancer].
    Haesner M; Buchali K; Pink V; Lips H
    Nuklearmedizin; 1992 Mar; 31(2):48-52. PubMed ID: 1373485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective use of strontium-89 in osseous metastases.
    Kuroda I
    Ann Nucl Med; 2012 Apr; 26(3):197-206. PubMed ID: 22160737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of strontium-89 palliative therapy in patients with painful bone metastases.
    Zorga P; Birkenfeld B; Listewnik MH; Piwowarska-Bilska H
    Ann Acad Med Stetin; 2011; 57(1):49-53; discussion 53. PubMed ID: 22593991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Question of the month--January 1995. What is the optimal dose of 89Sr for bone pain palliation?
    Khader Z
    Nucl Med Commun; 1995 Apr; 16(4):306. PubMed ID: 7542759
    [No Abstract]   [Full Text] [Related]  

  • 13. [Possibilities of systemic radiotherapy with high-purity 89Sr chloride in the treatment of bone metastases].
    Fomin DK; Tararukhina OB; Nazarov AA
    Vestn Rentgenol Radiol; 2012; (2):29-31. PubMed ID: 22730757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum E-selectin concentration after 89Sr-chloride therapy for metastatic prostate cancer bone pain.
    Papatheofanis FJ
    J Nucl Med; 2000 Jun; 41(6):1021-4. PubMed ID: 10855628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.
    Pons F; Herranz R; Garcia A; Vidal-Sicart S; Conill C; Grau JJ; Alcover J; Fuster D; Setoain J
    Eur J Nucl Med; 1997 Oct; 24(10):1210-4. PubMed ID: 9323260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.
    Kraeber-Bodéré F; Campion L; Rousseau C; Bourdin S; Chatal JF; Resche I
    Eur J Nucl Med; 2000 Oct; 27(10):1487-93. PubMed ID: 11083537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A process for the recovery of strontium from the urine of patients injected with 89Sr.
    Argiro G; Atzei G; Boemi S; Cipriani C; Shukla SK; Rossi G; Sedda AF
    Appl Radiat Isot; 1998 Jul; 49(7):777-8. PubMed ID: 9570096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of metastatic bone pain with strontium-89.
    Robinson RG; Spicer JA; Preston DF; Wegst AV; Martin NL
    Int J Rad Appl Instrum B; 1987; 14(3):219-22. PubMed ID: 3667305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone pain palliation with strontium-89 in breast cancer patients with bone metastases and refractory bone pain.
    Berna L; Carrio I; Alonso C; Ferré J; Estorch M; Torres G
    Eur J Nucl Med; 1995 Oct; 22(10):1101-4. PubMed ID: 8542891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone pain palliation with strontium-89 in cancer patients with bone metastases.
    Giammarile F; Mognetti T; Resche I
    Q J Nucl Med; 2001 Mar; 45(1):78-83. PubMed ID: 11456379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.